Tag: Clinic

Trinity Biotech plc gets a "buy" rating from StockNews.com analysts, spotlighting potential for investors with a focus on its diagnostic ...

Discover the booming VRET market, driven by tech advances and mental health needs, expected to grow at a 33.90% CAGR ...

Aerovate Therapeutics stock downgraded by BTIG after AV-101 trial setback; mixed analyst views and future pivotal readouts crucial for investors.

Nexalin shares are 1% shorted; 52-week range $0.25-$3.40. Market cap: $6.69M, PE ratio: -1.36, beta: 5.13. Qtr EPS: -$0.10; ROE: ...

Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.

Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...

ShockWave Medical Inc. achieved record revenue growth in 2023, forecasting further expansion in 2024. Strategic moves and new product launches ...

Bio-Rad Laboratories reports Q4 2023 net sales decline amidst biotech challenges. Full-year 2023 net sales also show a decrease. However, ...

Spectral AI has appointed Dr. J. Michael DiMaio to its Board of Directors as a non-executive member. This move strengthens ...

Cidara Therapeutics receives $11.1 million milestone payment from Mundipharma for European approval of new antifungal drug, Rezzayo. Analysts see potential ...